HomeMarket NewsSmall CapsWhy Vistagen Therapeutics Shares Are Trading Higher By Around 13%; Here Are...

Why Vistagen Therapeutics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Actionable Trade Ideas

always free


Why Vistagen Therapeutics Shares Are Trading Higher By Around 13%

Vistagen Therapeutics, Inc. (VTGN) shares are on the rise, trading higher by approximately 13% in pre-market trading. The surge comes after Citadel Advisors LLC revealed a 5.6% stake in the company through a 13G filing. This news has generated significant investor interest and contributed to the uptick in share price.

Gainers: Stocks Making Moves Pre-Market

Several other stocks have also experienced significant movements in pre-market trading:

SciSparc Ltd. (SPRC)

SciSparc Ltd. shares saw a surge of 79.5%, reaching $5.08 in pre-market trading. This increase follows a previous decline of around 7% on Monday. The company recently regained compliance with Nasdaq’s Minimum Bid Price Notification, which has helped restore investor confidence.

WiSA Technologies, Inc. (WISA)

WiSA Technologies, Inc. shares rose by 76.4% to $0.4380 in pre-market trading. This follows a 40% decline on Monday. The increase can be attributed to the company’s announcement of the pricing of a $4.8 million public offering of Series B convertible redeemable preferred stock and warrants.

Athersys, Inc. (ATHX)

Athersys, Inc. shares gained 51.5% to $0.1487 in pre-market trading. The increase in share price is due to Athersys extending near-term liquidity with proceeds from warrant inducement and a global ARDS license with Healios. This move demonstrates the company’s commitment to exploring strategic alternatives.

Aurora Mobile Limited (JG)

Aurora Mobile Limited shares climbed by 50.8% to $0.2005 in pre-market trading. This follows an 8% gain on Monday. The company’s consistent upward movement reflects its growing appeal to investors.

ZW Data Action Technologies Inc. (CNET)

ZW Data Action Technologies Inc. saw a rise of 30.8% in pre-market trading, with shares reaching $1.23. This increase follows a 13% decline on Monday. The company’s resilience in the face of recent market fluctuations has generated positive investor sentiment.

Losers: Stocks Experiencing Declines Pre-Market

While some stocks are gaining momentum, others are facing declines in pre-market trading:

Nuvve Holding Corp. (NVVE)

Nuvve Holding Corp. shares dipped by 33.5% to $0.2599 in pre-market trading. This follows a gain of over 9% on Monday. The decline can be attributed to market fluctuations and profit-taking by investors.

NetScout Systems, Inc. (NTCT)

NetScout Systems, Inc. shares fell by 23% to $21.24 in pre-market trading. The company reported weak preliminary results for the second quarter and lowered its FY24 guidance. These factors have negatively impacted investor sentiment.

Processa Pharmaceuticals, Inc. (PCSA)

Processa Pharmaceuticals, Inc. shares fell by 18.6% to $0.4547 in pre-market trading, following a 16% jump on Monday. The fluctuation in share price is likely due to market volatility and profit-taking.

MingZhu Logistics Holdings Limited (YGMZ)

MingZhu Logistics Holdings Limited shares experienced a drop of 14.5% to $0.5731 in pre-market trading. This decline follows a significant increase of approximately 38% on Monday. Market corrections and profit-taking by investors likely contributed to the decrease in share price.

Rani Therapeutics Holdings, Inc. (RANI)

Rani Therapeutics Holdings, Inc. shares fell by 13.5% to $1.90 in pre-market trading after gaining 11% on Monday. The decline may be attributed to profit-taking and market corrections.

Ambrx Biopharma Inc. (AMAM)

Ambrx Biopharma Inc. shares declined by 13.4% to $9.90 in pre-market trading. This comes after a 19% decline on Monday. The company recently shared updated safety and efficacy data from a Phase 1/2 trial, which may have influenced investor sentiment.

22nd Century Group, Inc. (XXII)

22nd Century Group, Inc. shares experienced an 11.9% decrease in pre-market trading, reaching $0.4840. The company recently announced a proposed public offering, which may have led to a decline in share price.

XTL Biopharmaceuticals Ltd. (XTLB)

XTL Biopharmaceuticals Ltd. shares fell by 11.8% to $0.7528 in pre-market trading, following a 15% dip on Monday. Market fluctuations and profit-taking by investors likely contributed to the decrease in share price.

NuCana plc (NCNA)

NuCana plc shares fell by 11.7% to $0.50 in pre-market trading. This comes after a decline of approximately 12% on Monday. The company presented data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023, which may have impacted investor sentiment.

Investors should continue to monitor these stocks and stay informed of any new developments that may impact their performance. As always, careful analysis and consideration of market trends are essential when making investment decisions.

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.